BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 31469423)

  • 1. Diagnostic value of serum D-dimer, CA125, and neutrophil-to-lymphocyte ratio in differentiating ovarian cancer and endometriosis.
    Chen L; Wang X; Shu J; Xu S; Wu Q; Yu Y
    Int J Gynaecol Obstet; 2019 Nov; 147(2):212-218. PubMed ID: 31469423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum D-dimer, albumin and systemic inflammatory response markers in ovarian clear cell carcinoma and their prognostic implications.
    Chen W; Zhong S; Shan B; Zhou S; Wu X; Yang H; Ye S
    J Ovarian Res; 2020 Aug; 13(1):89. PubMed ID: 32771026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utility of human epididymal protein 4, cancer antigen 125, and risk for malignancy algorithm in ovarian cancer and endometriosis.
    Kadija S; Stefanovic A; Jeremic K; Radojevic MM; Nikolic L; Markovic I; Atanackovic J
    Int J Gynecol Cancer; 2012 Feb; 22(2):238-44. PubMed ID: 22214964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Neutrophil-to-Lymphocyte Ratio Combined With CA-125 to Distinguish Endometriomas From Other Benign Ovarian Cysts.
    Tokmak A; Yildirim G; Öztaş E; Akar S; Erkenekli K; Gülşen P; Yilmaz N; Uğur M
    Reprod Sci; 2016 Jun; 23(6):795-802. PubMed ID: 26692541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnostic value of the combination of hemoglobin, CA199, CA125, and HE4 in endometriosis.
    Chen T; Wei JL; Leng T; Gao F; Hou SY
    J Clin Lab Anal; 2021 Sep; 35(9):e23947. PubMed ID: 34405450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on the predictive significance of PLR, SII and RPR in ovarian endometriotic cyst].
    Li MM; Tang XH; Wang LM
    Zhonghua Fu Chan Ke Za Zhi; 2023 Sep; 58(9):672-679. PubMed ID: 37724384
    [No Abstract]   [Full Text] [Related]  

  • 7. Noninvasive diagnosis of moderate to severe endometriosis: the platelet-lymphocyte ratio cannot be a neoadjuvant biomarker for serum cancer antigen 125.
    Yang H; Zhu L; Wang S; Lang J; Xu T
    J Minim Invasive Gynecol; 2015; 22(3):373-7. PubMed ID: 23850516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic performance of human epididymis protein 4 compared to a combination of biophysical and biochemical markers to differentiate ovarian endometriosis from epithelial ovarian cancer in premenopausal women.
    Nikolova T; Zivadinovic R; Evtimovska N; Klisarovska V; Stanojevic M; Georgievska J; Nikolova N
    J Obstet Gynaecol Res; 2017 Dec; 43(12):1870-1879. PubMed ID: 29027715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The differential diagnostic value and clinical significance of serum HE4 in ovarian disease with elevated CA125.
    Li W; Wang D
    Arch Gynecol Obstet; 2020 May; 301(5):1219-1225. PubMed ID: 32266526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Europium Nanoparticle-Based Sialyl-Tn Monoclonal Antibody Discriminates Epithelial Ovarian Cancer-Associated CA125 from Benign Sources.
    Gidwani K; Nadeem N; Huhtinen K; Kekki H; Heinosalo T; Hynninen J; Perheentupa A; Poutanen M; Carpen O; Pettersson K; Lamminmäki U
    J Appl Lab Med; 2019 Nov; 4(3):299-310. PubMed ID: 31659068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of CA125/CEA ratio and ultrasound parameters in identifying metastases to the ovaries in patients with multilocular and multilocular-solid ovarian masses.
    Moro F; Pasciuto T; Djokovic D; Di Legge A; Granato V; Moruzzi MC; Mancari R; Zannoni GF; Fischerova D; Franchi D; Scambia G; Testa AC
    Ultrasound Obstet Gynecol; 2019 Jan; 53(1):116-123. PubMed ID: 29978587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential blood count as triage tool in evaluation of pelvic masses.
    Cramer DW; Benjamin Iv WJ; Vitonis AF; Berkowitz R; Goodman A; Matulonis U
    Int J Gynecol Cancer; 2021 May; 31(5):733-743. PubMed ID: 32487682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of human epididymis 4, D-dimer, and fibrinogen compared with CA 125 alone in triaging women presenting with pelvic masses: a retrospective cohort study.
    McKendry K; Duff S; Huang Y; Redha M; Scanlon Á; Abu Saadeh F; Gleeson N; O'Leary J; Norris L; O'Toole S
    Acta Obstet Gynecol Scand; 2021 Jul; 100(7):1239-1247. PubMed ID: 33590896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role and clinical significance of coagulation and inflammatory factors in moderate and severe ovarian endometriosis].
    Lin Q; Ding SJ; Zhu TH; Li TT; Huang XF; Zhang XM
    Zhonghua Fu Chan Ke Za Zhi; 2018 Mar; 53(3):167-171. PubMed ID: 29609230
    [No Abstract]   [Full Text] [Related]  

  • 15. Neutrophil-to-lymphocyte ratio as an adjunct to CA-125 for the diagnosis of endometriosis.
    Cho S; Cho H; Nam A; Kim HY; Choi YS; Park KH; Cho DJ; Lee BS
    Fertil Steril; 2008 Dec; 90(6):2073-9. PubMed ID: 18555226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic roles of neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, platelet-to-lymphocyte ratio, C-reactive protein, and cancer antigen 125 for ovarian cancer.
    Ye L; Zhou G; Zhou L; Wang D; Xiong S; Liu C; Zhang G
    J Int Med Res; 2023 Dec; 51(12):3000605231218557. PubMed ID: 38130127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance and predictors of the neutrophil-to-lymphocyte ratio in ovarian cancer.
    Williams KA; Labidi-Galy SI; Terry KL; Vitonis AF; Welch WR; Goodman A; Cramer DW
    Gynecol Oncol; 2014 Mar; 132(3):542-50. PubMed ID: 24462730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of Serum Human Epididymis Protein 4 and Cancer Antigen 125 in Distinguishing Type I and Type II Epithelial Ovarian Cancers.
    Yanaranop M; Jantarateptewan N; Tiyayon J; Nakrangsee S
    Int J Gynecol Cancer; 2018 Jul; 28(6):1058-1065. PubMed ID: 29975290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative plasma D-dimer level is a useful prognostic marker in ovarian cancer.
    Yamada Y; Kawaguchi R; Iwai K; Niiro E; Morioka S; Tanase Y; Kobayashi H
    J Obstet Gynaecol; 2020 Jan; 40(1):102-106. PubMed ID: 31335252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum HE4 as a useful biomarker in discriminating ovarian cancer from benign pelvic disease.
    Zheng H; Gao Y
    Int J Gynecol Cancer; 2012 Jul; 22(6):1000-5. PubMed ID: 22426406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.